Free cookie consent management tool by TermsFeed Policy Generator

Ensayos Clínicos

A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF BIMEKIZUMAB IN THE TREATMENT OF STUDY PARTICIPANTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS, ANKYLOSING SPONDYLITIS, AND NONRADIOGRAPHIC AXIAL SPONDYLOARTHRIT

Ficha Técnica

Investigador Principal

EDUARDO COLLANTES ESTEVEZ

Promotor

UCB PHARMA

ESTADO

ACTIVO

DEPARTAMENTO

Reumatología

Código EudraCT: 2019-004163-47

Número protocolo: AS0014

Fecha Inicio: 2020-11-26

Fecha Fin: 2024-06-30